@the1andonlyjenn.bsky.socialPregaming my wedding day with Biocare #glp1 #wedding #marriage #protein #pregame
@the1andonlyjenn.bsky.socialIโm getting married in like 7 hours and Iโm terrified!! #wedding #marriage #glp1
@quietingfoodnoise.bsky.socialBinge eating: I went grocery shopping to hurt myself with food
๐๏ธ Quieting the Food Noise | A GLP-1 Diary with Sarah
#BingeEating #FoodNoise #GLP1 #Ozempic #QuietingTheFoodNoise
@robinexclpoint.bsky.social
@quietingfoodnoise.bsky.socialBeing haunted by โfood noiseโ is no joke
@the1andonlyjenn.bsky.socialWhat is โthe natural wayโ? Are things like keto, nutrisystems, slimfast and we considered the natural way? Or are those considered cheating too because they are aiding in your ability to be in a deficit? Let me know your thoughts in the comments! #healthjourney #glp1 #healthandwellness
@replaye.bsky.socialNovo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
replaye.com/novo-is-bett...
@obesitysociety.bsky.socialMicrodosing GLP-1 and tirzepatide offers affordable, tolerable obesity care but involves tradeoffs. ๐ Read: https://ow.ly/QAvP50ZRAQn #ObesityResearch #GLP1 #Tirzepatide #ObesityCare #ObesityJournal
@dogman868.bsky.socialGLP-1-based treatment: Mayo Clinic study identifies an obesity subtype that may respond especially well
โฆRead More ยป sweettntmagazine.com/glp-1-based-...
#Obesity #MayoClinic #GLP1 #Tirzepatide #PrecisionMedicine #WeightLossJourney #MedicalResearch #HealthTech #ObesityTreatment #SweetTNTMagazine
@chjreportinghealth.bsky.socialJoin us for our next free webinar!
๐ ๐ช๐ต๐ผ ๐๐ฒ๐๐ ๐๐ฐ๐ฐ๐ฒ๐๐ ๐๐ผ ๐๐ฟ๐ฒ๐ฎ๐ธ๐๐ต๐ฟ๐ผ๐๐ด๐ต ๐๐ฟ๐๐ด๐?
๐๏ธ Thursday, October 1, 2026
๐ฆ 11:30 am PT
๐ Register: bit.ly/BreakthroughDrugs
#ASCJ #HealthReporting #HealthJournalism #GLP1 #Pharmaceuticals
@jamahealthforum.comIn Medicaid, covering obesity-labeled #GLP1 receptor agonists was associated with higher obesity-labeled use, while total glucagon-like peptide-1 receptor agonist use increased less, suggesting possible substitution across label indications. ja.ma/4xPkKxn
@gmj-georgia.bsky.socialObesity's disease classification has accelerated GLP-1 development and insurance coverageโbut Max Moser argues in STAT News that the framing โฆ #Diseaseclassification #GLP1 #Healthcarepolicy #Obesity #Pharmaceuticalindustry #Diseaseclassification #GLP1 #Healthcarepolicy #Obesity #Pharmaceuticaliโฆ
@replaye.bsky.socialPopular weight-loss drugs may play surprising role in cancer outcomes
replaye.com/popular-weig...
@ajpakpour.bsky.socialRetatrutide is getting a lot of attention. But what does the research actually show?
Triple agonist. GLP-1 + GIP + glucagon receptor activity. Major weight-loss results in clinical trialsโand still investigational.
@thegrocer.bsky.socialThe popularisation of #GLP1 weight-loss drugs has driven a rebound in M&A in snacking companies around the world
@obesitysociety.bsky.socialAs obesity meds transform treatment, new questions arise. Explore impacts and research in the special issue: https://onlinelibrary.wiley.com/toc/1930739x/2026/34/S2 #ObesityResearch #ObesityMedicine #GLP1 #ObesityCare
@pccs.bsky.socialClosing #PCCS2026 with GLP-1s and lifestyle medicine.
The message for primary care: match treatment to the individual, support sustainable lifestyle change and think beyond weight alone to wider cardiometabolic health.
@health-cares.bsky.socialGLP-1 Review 2026: Benefits, Uses & Key Features Explained
Explore GLP-1, its key features, and potential benefits in this simple guide.
Visit Now: www-glp1.com
@freegardener.bsky.social10-15% of people on GLP-1 drugs lose little to no weight. Scientists are racing to understand whyโand to build personalized treatments for the #GLP1 #WeightLoss #ObesityResearch #Health
https://freegardner.com/sci_scout/why-some-people-lose-nothing-on-glp-1-drugs.html
@cbarbermd.bsky.social